
Patent Litigation MonitorPharmaceutical-BiotechnologyIPD monitors and analyzes a wide array of patent infringement litigation within the pharmaceuticals and biotechnology sector. We will publish three reports a month in the Pharma-Biotech space, either analyzing ongoing patent infringement litigation that may affect a company’s stock price, or evaluating a company’s patent portfolio. Within the Pharma-Biotech product, we will generally monitor approximately 20-25 ongoing patent infringement lawsuits at any given time, focusing primarily on those lawsuits and companies that are of greatest interest to the financial community. As a subscriber to the Pharma-Biotech service you will receive the following services. |
![]() ![]() ![]() |


The Investorside Research Association certifies its members have no investment banking conflicts.


